Osteoporosis Clinical Trials in New York

Showing 41-60 of 62 trials

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

NCT00000623

The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphasis will be on clinical trials that help identify optimal therapy. Therapeutic trials may involve investigational drugs, drugs already approved but not currently used, and drugs currently used.

Anemia, Cooley'sBeta-ThalassemiaHematologic Diseases+4 more

Carelon Research1,000 participantsStarted Jul 2000

Oakland, California, United States • Boston, Massachusetts, United States • New York, New York, United States +2 more locations

COMPLETED< 1 mile

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

NCT00069004

The purpose of this study is to assess the prevalence of metabolic and physical abnormalities in HIV infected (via mother-to-child transmission) and uninfected children and youth. Metabolism, body composition, bone density, and other factors will be assessed in relationship to participants' exposure to highly active antiretroviral therapy (HAART).

HIV InfectionsHIV-Associated Lipodystrophy SyndromeHIV Lipodystrophy Syndrome+4 more

National Institute of Allergy and Infectious Diseases (NIAID)450 participantsStarted Oct 2003

Birmingham, Alabama, United States • Alhambra, California, United States • Long Beach, California, United States +35 more locations

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Osteoporosis Trials in Other Cities

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Effects of Black Cohosh on Menopausal Hot Flashes

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

A Study for the Transdermal Application of Teriparatide

Other Conditions in New York